approval
saveOTULFI (USTEKINUMAB-AAUZ) — FDA approval
community read0 votes
Sponsor: FRESENIUS KABI USA. Form: INJECTABLE. Route: INJECTION
view source ↗Data sources
last refreshed 6mo ago
Found something off?
drug timeline · 8
- approvalOTULFI (USTEKINUMAB-AAUZ) — FDA approvalJan 15, 2026 · 309d ago
- approvalOTULFI (USTEKINUMAB-AAUZ) — FDA approvalAug 14, 2025 · 463d ago
- approvalOTULFI (USTEKINUMAB-AAUZ) — FDA approvalAug 14, 2025 · 463d ago
- approvalOTULFI (USTEKINUMAB-AAUZ) — FDA approvalApr 30, 2025 · 569d ago
- approvalOTULFI (USTEKINUMAB-AAUZ) — FDA approvalApr 14, 2025 · 585d ago
- approvalOTULFI (USTEKINUMAB-AAUZ) — FDA approvalMar 21, 2025 · 609d ago
- approvalOTULFI (USTEKINUMAB-AAUZ) — FDA approvalFeb 19, 2025 · 639d ago
- approvalOTULFI (USTEKINUMAB-AAUZ) — FDA approvalSep 27, 2024 · 784d ago
same company · ±60 days · 6
- recallDenver Solutions, LLC DBA Leiters Health recall (Cls II)Apr 30, 2025
- recallDenver Solutions, LLC DBA Leiters Health recall (Cls II)Apr 30, 2025
- approvalOTULFI: OTULFI (USTEKINUMAB-AAUZ) — FDA approvalApr 30, 2025
- approvalTYENNE: TYENNE (TOCILIZUMAB-AAZG) — FDA approvalMay 12, 2025
- approvalOTULFI: OTULFI (USTEKINUMAB-AAUZ) — FDA approvalApr 14, 2025
- approvalSTIMUFEND: STIMUFEND (PEGFILGRASTIM-FPGK) — FDA approvalMar 26, 2025
comments(0)
5-min edit window · permanent after that